{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:57:25Z","timestamp":1775469445796,"version":"3.50.1"},"reference-count":44,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Respir Care"],"published-print":{"date-parts":[[2023,5]]},"abstract":"\n BACKGROUND:<\/jats:title>\n Whereas pulmonary exacerbations and aerobic fitness play a key role in the prognosis of cystic fibrosis (CF), the use of ventilatory threshold data as markers of exacerbation risk has been scarcely addressed. This study sought to examine the association between aerobic fitness, assessed through ventilatory threshold variables recorded during cardiopulmonary exercise testing (CPET), and the risk of exacerbations in individuals with CF.<\/jats:p>\n <\/jats:sec>\n \n METHODS:<\/jats:title>\n Participants of this retrospective cohort study were subjects from 6 y of age. Over a 4-y period, the following data were recorded: lung function indicators, CPET variables, time to first exacerbation and antibiotic use, along with demographic, clinical, and anthropometric data.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n \n The mean age of 20 subjects included was 16 \u00b1 5.4 y. Univariate regression analysis revealed that lung function (FEV\n 1<\/jats:sub>\n : Cox hazard ratio [HR] 0.97,\n P<\/jats:italic>\n = .03; and forced expiratory flow between 25\u201375% of vital capacity [FEF\n 25\u201375<\/jats:sub>\n ]: Cox HR 0.98,\n P<\/jats:italic>\n = .036) and aerobic fitness (oxygen consumption [V\u0307\n \n O\n 2<\/jats:sub>\n <\/jats:sub>\n ] at ventilatory threshold: Cox HR 0.94,\n P<\/jats:italic>\n = .01; and ventilatory equivalent for carbon dioxide [V\u0307\n E<\/jats:sub>\n \/V\u0307\n \n CO\n 2<\/jats:sub>\n <\/jats:sub>\n ] at ventilatory threshold: Cox HR 1.13,\n P<\/jats:italic>\n = .049) were associated with exacerbation risk, whereas in the multivariate model, only V\u0307\n \n O\n 2<\/jats:sub>\n <\/jats:sub>\n at the ventilatory threshold (%max) (Cox HR 0.92,\n P<\/jats:italic>\n = .01) had a significant impact on this risk. Consistently, individuals experiencing exacerbation had significantly lower V\u0307\n \n O\n 2<\/jats:sub>\n <\/jats:sub>\n values (%max) at the ventilatory threshold (\n P<\/jats:italic>\n = .050) and higher ventilatory equivalent for oxygen consumption (V\u0307\n E<\/jats:sub>\n \/V\u0307\n \n O\n 2<\/jats:sub>\n <\/jats:sub>\n ) (\n P<\/jats:italic>\n = .040) and V\u0307\n E<\/jats:sub>\n \/V\u0307\n \n O\n 2<\/jats:sub>\n <\/jats:sub>\n (\n P<\/jats:italic>\n = .037) values at the ventilatory threshold. Time to exacerbation was significantly correlated with V\u0307\n \n O\n 2<\/jats:sub>\n <\/jats:sub>\n at the ventilatory threshold (r = 0.50,\n P<\/jats:italic>\n = .02), V\u0307\n E<\/jats:sub>\n \/V\u0307\n \n O\n 2<\/jats:sub>\n <\/jats:sub>\n (r = \u22120.48,\n P<\/jats:italic>\n = .02), and V\u0307\n E<\/jats:sub>\n \/V\u0307\n \n CO\n 2<\/jats:sub>\n <\/jats:sub>\n (r = \u22120.50,\n P<\/jats:italic>\n = .02).\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n \n Our results suggest an association between CPET variables at the ventilatory threshold and exacerbations. Percentage V\u0307\n \n O\n 2<\/jats:sub>\n <\/jats:sub>\n at the ventilatory threshold could serve as a complementary variable to monitor exacerbations in people with CF.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.4187\/respcare.10428","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T13:39:28Z","timestamp":1680615568000},"page":"620-627","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Ventilatory Threshold and Risk of Pulmonary Exacerbations in Cystic Fibrosis"],"prefix":"10.1177","volume":"68","author":[{"given":"Nat\u00e1lia E","family":"Campos","sequence":"first","affiliation":[{"name":"Laboratory of Pediatric Physical Activity, Infant Center, Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda M","family":"Vendrusculo","sequence":"additional","affiliation":[{"name":"Laboratory of Pediatric Physical Activity, Infant Center, Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"P\u00e9rez-Ruiz","sequence":"additional","affiliation":[{"name":"Department of Health and Human Performance, Facultad de Ciencias de la Actividad F\u00edsica y del Deporte, Universidad Polit\u00e9cnica de Madrid, Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcio V F","family":"Donadio","sequence":"additional","affiliation":[{"name":"Laboratory of Pediatric Physical Activity, Infant Center, Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil; and Department of Physiotherapy, Facultad de Medicina y Ciencias de la Salud, Universitat Internacional de Catalunya, Barcelona, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00576-6"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2005.085019"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.3.9802112"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2017.02.007"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.10.847"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.10.019"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2011.161117"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.152"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0395-2020"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-015-0151-7"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1980.tb07092.x"},{"key":"e_1_3_2_13_2","first-page":"28","article-title":"Exercise testing in cystic fibrosis: who and why?","volume":"27","author":"Urquhart DS","year":"2018","unstructured":"Urquhart DS, , Saynor ZL. Exercise testing in cystic fibrosis: who and why?. Paediatr Respir Rev, 2018; 27:28\u201332.","journal-title":"Paediatr Respir Rev"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22878"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06185"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874192401004010127"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2003.07.014"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl404"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201806-1110OC"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1986.60.6.2020"},{"key":"e_1_3_2_21_2","first-page":"72","article-title":"Clinical interpretation of cardiopulmonary exercise testing in cystic fibrosis and implications for exercise counselling","volume":"24","author":"Urquhart DS","year":"2017","unstructured":"Urquhart DS, , Vendrusculo FM. Clinical interpretation of cardiopulmonary exercise testing in cystic fibrosis and implications for exercise counselling. Paediatr Respir Rev, 2017; 24:72\u201378.","journal-title":"Paediatr Respir Rev"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/children8060527"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.04.005"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(02)00141-8"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(11)60012-X"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.01.001"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10112662"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01441-2019"},{"issue":"10","key":"e_1_3_2_31_2","first-page":"211","article-title":"ATS\/ACCP statement on cardiopulmonary exercise testing","volume":"167","author":"Weisman IM","year":"2001","unstructured":"Weisman IM, , Marciniuk D, , Martinez FJ, , Frank SE, , Sue D, , Myers B, et al. ATS\/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med, 2001; 167(10):211\u2013277.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10092014"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201612-2574OC"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20023"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.926248"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbr.2018.05.020"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnma.2021.08.038"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2214.2008.00900.x"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.11.071"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.12.014"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-017-3024-7"},{"issue":"5","key":"e_1_3_2_42_2","first-page":"467","article-title":"Cardiopulmonary exercise test: background, applicability, and interpretation","volume":"107","author":"Herdy AH","year":"2016","unstructured":"Herdy AH, , Ritt LEF, , Stein R, , de Ara\u00fajo CGS, , Milani M, , Meneghelo RS, et al. Cardiopulmonary exercise test: background, applicability, and interpretation. Arq Bras Cardiol, 2016; 107(5):467\u2013481.","journal-title":"Arq Bras Cardiol"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1044-8"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00030.2019"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02036-2016"}],"container-title":["Respiratory Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.4187\/respcare.10428","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4187\/respcare.10428","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4187\/respcare.10428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T08:57:43Z","timestamp":1775465863000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4187\/respcare.10428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.4187\/respcare.10428"],"URL":"https:\/\/doi.org\/10.4187\/respcare.10428","relation":{},"ISSN":["0020-1324"],"issn-type":[{"value":"0020-1324","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,4]]}}}